يعرض 51 - 60 نتائج من 9,846 نتيجة بحث عن '"Glucagon-Like Peptide-1 Receptor"', وقت الاستعلام: 0.97s تنقيح النتائج
  1. 51
    دورية أكاديمية
    Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium–Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.

    المؤلفون: Gallo, Giovanna1 (AUTHOR) giovanna.gallo@uniroma1.it, Volpe, Massimo2 (AUTHOR) massimo.volpe@sanraffaele.it

    المصدر: International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 5, p2484. 17p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *HEART failure, *CORONARY artery disease, *PHARMACODYNAMICS, *PEPTIDE receptors

    النص الكامل

    أضف إلى المفضلة
  2. 52
    دورية أكاديمية
    Glucagon‐like peptide‐1 analogues in monogenic syndromic obesity: Real‐world data from a large cohort of Alström syndrome patients.

    المؤلفون: Ali, Sadaf1,2 (AUTHOR), Baig, Shanat1,2 (AUTHOR), Wanninayake, Subadra1 (AUTHOR), da Silva Xavier, Gabriela2 (AUTHOR), Dawson, Charlotte1 (AUTHOR), Paisey, Richard3 (AUTHOR), Geberhiwot, Tarekegn1,2 (AUTHOR) tarekegn.geberhiwot@uhb.nhs.uk

    المصدر: Diabetes, Obesity & Metabolism. Mar2024, Vol. 26 Issue 3, p989-996. 8p.

    مصطلحات موضوعية: *INSULIN, *GLUCAGON-like peptide-1 receptor, *NON-alcoholic fatty liver disease, *HDL cholesterol, *LDL cholesterol, *OBESITY, *PEPTIDE receptors


    أضف إلى المفضلة
  3. 53
    دورية أكاديمية
    A comment on tirzepatide versus glucagon‐like peptide‐1 receptor agonists and heart rate with regard to 'Impact of a dual glucose‐dependent insulinotropic peptide/glucagon‐like peptide‐1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta‐analysis'

    المؤلفون: Goldenberg, Ronald M.1 (AUTHOR) ronaldgoldenberg@gmail.com

    المصدر: Diabetes, Obesity & Metabolism. Mar2024, Vol. 26 Issue 3, p1138-1141. 4p.

    مصطلحات موضوعية: *PEPTIDE receptors, *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *HEART beat, *TYPE 2 diabetes, *GASTRIC inhibitory polypeptide


    أضف إلى المفضلة
  4. 54
    دورية أكاديمية
    Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial

    المؤلفون: Wu, Jingying1 (AUTHOR), Zhou, Renpeng1 (AUTHOR), Zhang, Qian1 (AUTHOR), Zhang, Qin1 (AUTHOR), Qin, Huiling1 (AUTHOR), Ye, Zi2 (AUTHOR), Xu, Yimei2 (AUTHOR), Feng, Sheng2 (AUTHOR), Shu, Chang2 (AUTHOR), Shen, Yu2 (AUTHOR), Fan, Yang2 (AUTHOR), Wang, Quanren2 (AUTHOR), Du, Yijun3 (AUTHOR) 2460679232@qq.com, Hu, Wei1 (AUTHOR) huwei@ahmu.edu.cn

    المصدر: Diabetes, Obesity & Metabolism. Mar2024, Vol. 26 Issue 3, p901-910. 10p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *WEIGHT loss, *SMALL molecules, *PHARMACODYNAMICS, *GLUCAGON receptors, *PEPTIDE receptors


    أضف إلى المفضلة
  5. 55
    دورية أكاديمية
    Glucagon‐like peptide‐1 receptor agonists and risk of thyroid cancer: A systematic review and meta‐analysis of randomized controlled trials.

    المؤلفون: Silverii, Giovanni Antonio1 (AUTHOR) giovanniantonio.silverii@unifi.it, Monami, Matteo1 (AUTHOR), Gallo, Marco2 (AUTHOR), Ragni, Alberto2 (AUTHOR), Prattichizzo, Francesco3 (AUTHOR), Renzelli, Valerio4 (AUTHOR), Ceriello, Antonio3 (AUTHOR), Mannucci, Edoardo1 (AUTHOR)

    المصدر: Diabetes, Obesity & Metabolism. Mar2024, Vol. 26 Issue 3, p891-900. 10p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *THYROID cancer, *RANDOMIZED controlled trials, *SEQUENTIAL analysis, *DISEASE risk factors


    أضف إلى المفضلة
  6. 56
    دورية أكاديمية
    Comparative effectiveness of glucagon-like peptide-1 receptor agonists on body composition and anthropometric indices: A protocol for a systematic review and network meta-analysis of randomized controlled trials.

    المؤلفون: Wachiraphansakul, Nuttaya1 (AUTHOR), Vongchaiudomchoke, Thanawat1 (AUTHOR), Manosroi, Worapaka2 (AUTHOR), Nochaiwong, Surapon3,4 (AUTHOR) surapon.nochaiwong@gmail.com

    المصدر: PLoS ONE. 2/26/2024, Vol. 19 Issue 2, p1-12. 12p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *RANDOMIZED controlled trials, *CLINICAL trial registries, *RESEARCH protocols, *ODDS ratio, *SEQUENTIAL analysis, *BODY composition

    النص الكامل

    أضف إلى المفضلة
  7. 57
    دورية أكاديمية
    Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study.

    المؤلفون: Htoo, Phyo T.1 (AUTHOR), Tesfaye, Helen1 (AUTHOR), Schneeweiss, Sebastian1 (AUTHOR), Wexler, Deborah J.2 (AUTHOR), Everett, Brendan M.3 (AUTHOR), Glynn, Robert J.1 (AUTHOR), Schmedt, Niklas4 (AUTHOR), Koeneman, Lisette5 (AUTHOR), Déruaz-Luyet, Anouk4 (AUTHOR), Paik, Julie M.1,6 (AUTHOR), Patorno, Elisabetta1 (AUTHOR) epatorno@bwh.harvard.edu

    المصدر: Cardiovascular Diabetology. 2/8/2024, Vol. 23 Issue 1, p1-12. 12p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *EMPAGLIFLOZIN, *MAJOR adverse cardiovascular events, *CHRONIC kidney failure, *MYOCARDIAL reperfusion

    النص الكامل

    أضف إلى المفضلة
  8. 58
    دورية أكاديمية
    Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us Cohort.

    المؤلفون: Aldhaleei, Wafa Ali1 (AUTHOR) aldhaleei.wafa@mayo.edu, Abegaz, Tadesse M.2 (AUTHOR) tadesse1.abegaz@famu.edu, Bhagavathula, Akshaya Srikanth3 (AUTHOR) akshaya.bhagavathula@ndsu.edu

    المصدر: Pharmaceuticals (14248247). Feb2024, Vol. 17 Issue 2, p199. 11p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *CROSS-sectional method, *SUMATRIPTAN

    الشركة/الكيان: NATIONAL Institutes of Health (U.S.)

    النص الكامل

    أضف إلى المفضلة
  9. 59
    دورية أكاديمية
    Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database.

    المؤلفون: Ruggiero, Rosanna1,2 (AUTHOR) rosanna.ruggiero@unicampania.it, Mascolo, Annamaria1,2 (AUTHOR) annamaria.mascolo@unicampania.it, Spezzaferri, Angela1,2 (AUTHOR), Carpentieri, Claudia1,2 (AUTHOR), Torella, Daniele3 (AUTHOR) dtorella@unicz.it, Sportiello, Liberata1,2 (AUTHOR), Rossi, Francesco1,2 (AUTHOR), Paolisso, Giuseppe4,5 (AUTHOR), Capuano, Annalisa1,2 (AUTHOR)

    المصدر: Pharmaceuticals (14248247). Feb2024, Vol. 17 Issue 2, p147. 11p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *SUICIDAL ideation, *DATABASES, *SUICIDE risk factors

    النص الكامل

    أضف إلى المفضلة
  10. 60
    دورية أكاديمية
    Liraglutide modulates morpho‐functional and inflammatory gastrointestinal responses in rats.

    المؤلفون: Gusmão‐Nascimento, Jhony Willams1 (AUTHOR), Nunes Cruz, Daniela Maione2 (AUTHOR), Almeida Gama, Loyane3 (AUTHOR), Luz Alves, Wellington David2 (AUTHOR), Machado, Mariana Pirani Rocha4 (AUTHOR), Corá, Luciana Aparecida1,5 (AUTHOR) luciana.cora@uncisal.edu.br, Américo, Madileine Francely2 (AUTHOR)

    المصدر: European Journal of Clinical Investigation. Feb2024, Vol. 54 Issue 2, p1-9. 9p.

    مصطلحات موضوعية: *LIRAGLUTIDE, *GLUCAGON-like peptide-1 receptor, *WHITE adipose tissue, *GASTROINTESTINAL motility, *GASTROPARESIS, *INFLAMMATION, *MORBID obesity


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث